|
ATE546528T1
(de)
|
2002-11-13 |
2012-03-15 |
Univ Jefferson |
Zusammensetzungen und verfahren zur diagnose und behandlung von krebs
|
|
WO2005013901A2
(en)
|
2003-07-31 |
2005-02-17 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding rnas
|
|
EP1713938A2
(en)
|
2004-02-09 |
2006-10-25 |
Thomas Jefferson University |
DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
|
|
CA2566519C
(en)
|
2004-05-14 |
2020-04-21 |
Rosetta Genomics Ltd. |
Micrornas and uses thereof
|
|
US7795419B2
(en)
*
|
2004-05-26 |
2010-09-14 |
Rosetta Genomics Ltd. |
Viral and viral associated miRNAs and uses thereof
|
|
EP2471924A1
(en)
|
2004-05-28 |
2012-07-04 |
Asuragen, INC. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
*
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
EP2990410A1
(en)
*
|
2004-08-10 |
2016-03-02 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides
|
|
DK1797183T3
(da)
*
|
2004-09-02 |
2012-10-01 |
Univ Yale |
Regulering af onkogener med mikrornas
|
|
ES2534300T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
WO2007044057A2
(en)
|
2005-02-24 |
2007-04-19 |
The Ohio State University Research Foundation |
Methods for quantifying microrna precursors
|
|
WO2007016548A2
(en)
|
2005-08-01 |
2007-02-08 |
The Ohio State University Research Foundation |
Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
|
|
EP1928807A4
(en)
*
|
2005-09-02 |
2011-05-04 |
Picobella Llc |
ONCOGENIC REGULATORS RNA FOR DIAGNOSIS AND THERAPY
|
|
US8481505B2
(en)
*
|
2005-09-12 |
2013-07-09 |
The Ohio State University Research Foundation |
Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
|
|
CA2624531A1
(en)
*
|
2005-10-05 |
2007-04-19 |
Carlo M. Croce |
Wwox gene, vectors containing the same, and uses in treatment of cancer
|
|
AU2012238336B8
(en)
*
|
2006-01-05 |
2014-08-07 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
|
|
AU2014203454B2
(en)
*
|
2006-01-05 |
2016-03-17 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
|
|
AU2016203848B2
(en)
*
|
2006-01-05 |
2017-12-14 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
|
|
WO2007081680A2
(en)
*
|
2006-01-05 |
2007-07-19 |
The Ohio State University Research Foundation |
Microrna expression abnormalities in pancreatic endocrine and acinar tumors
|
|
EP2484782B1
(en)
*
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
AU2007205234B2
(en)
|
2006-01-05 |
2012-07-12 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
|
|
EP2522748A1
(en)
*
|
2006-03-02 |
2012-11-14 |
The Ohio State University |
MicroRNA expression profile associated with pancreatic cancer
|
|
ES2446362T3
(es)
|
2006-03-20 |
2014-03-07 |
The Ohio State University Research Foundation |
Huellas de microARN durante megacariocipoyesis humana
|
|
US8700335B2
(en)
|
2006-05-18 |
2014-04-15 |
Caris Mpi, Inc. |
System and method for determining individualized medical intervention for a disease state
|
|
US8768629B2
(en)
*
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
WO2007147067A2
(en)
*
|
2006-06-14 |
2007-12-21 |
Rosetta Inpharmatics Llc |
Methods and compositions for regulating cell cycle progression
|
|
ES2425387T3
(es)
|
2006-07-13 |
2013-10-15 |
The Ohio State University Research Foundation |
Mir-106a para diagnosticar adenocarcinoma de colon de pronóstico de supervivencia pobre
|
|
WO2008036741A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
|
US8071292B2
(en)
|
2006-09-19 |
2011-12-06 |
The Ohio State University Research Foundation |
Leukemia diagnostic methods
|
|
WO2008054828A2
(en)
|
2006-11-01 |
2008-05-08 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
EP2102341A2
(en)
*
|
2006-12-08 |
2009-09-23 |
Asuragen, INC. |
Mirna regulated genes and pathways as targets for therapeutic intervention
|
|
JPWO2008090930A1
(ja)
*
|
2007-01-23 |
2010-05-20 |
オリンパス株式会社 |
癌の診断方法
|
|
JP2010516291A
(ja)
|
2007-01-31 |
2010-05-20 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
急性骨髄性白血病(aml)の診断、予後及び治療のためのマイクロrnaに基づく方法及び組成物
|
|
EP2125032A4
(en)
|
2007-02-20 |
2011-02-23 |
Mayo Foundation |
CANCER TREATMENT WITH VIRAL NUCLEIC ACID
|
|
CN101688240A
(zh)
*
|
2007-04-10 |
2010-03-31 |
国立台湾大学 |
通过微rna预测癌症患者的治疗后存活预期
|
|
CN101827941B
(zh)
*
|
2007-04-30 |
2014-07-16 |
俄亥俄州立大学研究基金会 |
用于区分胰腺癌与正常胰腺功能和/或慢性胰腺炎的方法
|
|
US8465917B2
(en)
|
2007-06-08 |
2013-06-18 |
The Ohio State University Research Foundation |
Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells
|
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
|
EP2173911B1
(en)
*
|
2007-07-31 |
2014-06-18 |
The Ohio State University Research Foundation |
Methods for reverting methylation by targeting dnmt3a and dnmt3b
|
|
EP2653561B1
(en)
|
2007-08-03 |
2016-03-02 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncRNAs
|
|
EP3028708A1
(en)
|
2007-08-22 |
2016-06-08 |
The Ohio State University Research Foundation |
Methods and compositions for inducing deregulation of epha7 and erk phosphorylation in human acute leukemias
|
|
EP3138926A3
(en)
*
|
2007-09-06 |
2017-04-05 |
The Ohio State University Research Foundation |
Microrna signatures in human ovarian cancer
|
|
US8361714B2
(en)
|
2007-09-14 |
2013-01-29 |
Asuragen, Inc. |
Micrornas differentially expressed in cervical cancer and uses thereof
|
|
US20090136465A1
(en)
|
2007-09-28 |
2009-05-28 |
Intrexon Corporation |
Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof
|
|
EP2212440A4
(en)
*
|
2007-10-11 |
2011-04-06 |
Univ Ohio State Res Found |
METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF ADENOCARCINOMES OF DISHES
|
|
WO2009055773A2
(en)
|
2007-10-26 |
2009-04-30 |
The Ohio State University Research Foundation |
Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
|
|
WO2009062169A2
(en)
|
2007-11-09 |
2009-05-14 |
The Board Of Regents Of The University Of Texas System |
Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
|
|
EP2225396A4
(en)
*
|
2007-11-30 |
2011-03-02 |
Univ Ohio State Res Found |
PROFILING AND SCREENING OF MICRO-RNA EXPRESSION IN PERIPHERAL BLOOD IN LUNG CANCER
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
US20110054009A1
(en)
*
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
|
|
JP2011517932A
(ja)
*
|
2008-02-28 |
2011-06-23 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
ヒト慢性リンパ球性白血病(ccl)と関連するマイクロrnaシグネチャーおよびその使用
|
|
US20090233297A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Elizabeth Mambo |
Microrna markers for recurrence of colorectal cancer
|
|
US20090253780A1
(en)
*
|
2008-03-26 |
2009-10-08 |
Fumitaka Takeshita |
COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
|
|
US8258111B2
(en)
|
2008-05-08 |
2012-09-04 |
The Johns Hopkins University |
Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
|
|
WO2009152300A1
(en)
|
2008-06-11 |
2009-12-17 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Use of mir-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
|
|
EP3075864A1
(en)
*
|
2008-10-14 |
2016-10-05 |
Caris MPI, Inc. |
Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
|
|
JP2012507300A
(ja)
*
|
2008-10-30 |
2012-03-29 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
Rnaパターンを評価する方法
|
|
GB2465088C
(en)
*
|
2008-10-30 |
2016-01-27 |
Caris Mpi Inc |
miRNA expression in the characterisation and classification of cancer
|
|
EP2350320A4
(en)
*
|
2008-11-12 |
2012-11-14 |
Caris Life Sciences Luxembourg Holdings |
METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
|
|
US8883995B2
(en)
|
2009-03-06 |
2014-11-11 |
Icahn School Of Medicine At Mount Sinai |
Live attenuated influenza virus vaccines comprising microRNA response elements
|
|
JP5812491B2
(ja)
|
2009-10-01 |
2015-11-11 |
国立研究開発法人国立がん研究センター |
腫瘍治療剤
|
|
EP2504452A4
(en)
|
2009-11-23 |
2014-06-11 |
Univ Ohio State Res Found |
MATERIALS AND METHODS FOR INFLUENCING GROWTH, MIGRATION AND INVASION OF TUMOR CELLS
|
|
AU2011223789A1
(en)
|
2010-03-01 |
2012-09-20 |
Caris Life Sciences Switzerland Holdings Gmbh |
Biomarkers for theranostics
|
|
KR20130043104A
(ko)
|
2010-04-06 |
2013-04-29 |
카리스 라이프 사이언스 룩셈부르크 홀딩스 |
질병용 순환 생물학적 지표들
|
|
WO2012065049A1
(en)
|
2010-11-12 |
2012-05-18 |
The Ohio State University Research Foundation |
Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
|
|
CA2817982C
(en)
|
2010-11-15 |
2020-06-30 |
The Regents Of The University Of Michigan |
Controlled release mucoadhesive systems
|
|
JP2014509852A
(ja)
|
2011-03-07 |
2014-04-24 |
ジ・オハイオ・ステート・ユニバーシティ |
マイクロRNA−155(miR−155)により誘導される変異誘発活性は炎症および癌を結び付ける
|
|
US9644241B2
(en)
|
2011-09-13 |
2017-05-09 |
Interpace Diagnostics, Llc |
Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
|
|
CA2852066A1
(en)
|
2011-10-14 |
2013-04-18 |
The Ohio State University |
Methods and materials related to ovarian cancer
|
|
EP2790735A4
(en)
|
2011-12-13 |
2015-12-09 |
Ohio State Innovation Foundation |
METHODS AND COMPOSITIONS RELATING TO MIR-21 AND MIR-29A, EXOSOME INHIBITION, AND CANCER METASTASIS
|
|
WO2013106766A2
(en)
*
|
2012-01-13 |
2013-07-18 |
The Research Foundation Of State University Of New York |
THERAPEUTIC INDICATIONS OF miR-1291
|
|
JP2015511121A
(ja)
|
2012-01-20 |
2015-04-16 |
ジ・オハイオ・ステート・ユニバーシティ |
浸潤性および予後に関する乳がんバイオマーカーシグネチャー
|
|
US9163235B2
(en)
|
2012-06-21 |
2015-10-20 |
MiRagen Therapeutics, Inc. |
Inhibitors of the miR-15 family of micro-RNAs
|
|
CA2879410C
(en)
|
2012-08-20 |
2018-06-26 |
National Cancer Center |
Agent for treating cancer
|
|
WO2015067710A2
(en)
*
|
2013-11-06 |
2015-05-14 |
Universite De Rennes 1 |
Tyrp1, a natural mirna sponge, and its use in managing human melanoma aggressiveness
|
|
CN104846086A
(zh)
*
|
2015-05-04 |
2015-08-19 |
四川大学华西第二医院 |
血浆miR-15b作为分子标记物在精子产生与功能评估中的应用
|
|
CN109295231A
(zh)
*
|
2017-11-03 |
2019-02-01 |
中国医学科学院基础医学研究所 |
Nok基因在慢性b淋巴细胞白血病诊断或治疗中的用途
|
|
US12551669B2
(en)
|
2020-07-15 |
2026-02-17 |
Biogen Ma Inc. |
Medical system including two access ports
|
|
IL299904B1
(en)
|
2020-07-20 |
2026-05-01 |
Cerebral Therapeutics Inc |
Liquid catheter device for recording brain status
|
|
US12605537B2
(en)
|
2022-02-15 |
2026-04-21 |
Biogen Ma Inc. |
Implantable medical device for use with or having recording electrode
|
|
WO2023249888A1
(en)
*
|
2022-06-21 |
2023-12-28 |
Curamir Therapeutics, Inc. |
Cytarabine-modified mirna for treating cancer
|
|
EP4417285B1
(en)
*
|
2023-02-16 |
2026-07-01 |
Sartorius BIA Separations d.o.o. |
PROCESS FOR PURIFICATION OF LIPID NANOPARTICLES
|